Rhabdomyosarcoma laboratory findings
|
Rhabdomyosarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Rhabdomyosarcoma laboratory findings On the Web |
|
American Roentgen Ray Society Images of Rhabdomyosarcoma laboratory findings |
|
Risk calculators and risk factors for Rhabdomyosarcoma laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: {{S.M}
Overview
Laboratory Findings
- The essential laboratory tests for patients for rhabdomyosarcoma are:[1][2]
- CBC:
- It may result into pancytopenia and anemia due to bone involvement.
- Liver function test ( LFT):
- LFT should be evaluated before chemotharapy and for assessment of liver metastasis.
- Renal function test:
- BUN and Creatinine levels should be evaluated before chemotherapy.
- Blood electrolytes such as sodium, potassium, chlorine, calcium, phosphorous, and magnesium:
- Hypercalcemia may occur.
- These tesets should be evaluated before chemotherapy.
- Coagulation studies:
- Disseminated intravascular coagulation may occur.
- CBC:
References
- ↑ Fiegl M, Weltermann A, Stindl R, Fonatsch C, Lechner K, Gisslinger H (1999). "Massive disseminated intravascular coagulation and hyperfibrinolysis in alveolar rhabdomyosarcoma: case report and review of the literature". Ann Hematol. 78 (7): 335–8. PMID 10466447.
- ↑ Kawasaki H, Takayama J, Nagasaki K, Yamaguchi K, Ohira M (1998). "Hypercalcemia in children with rhabdomyosarcoma". J Pediatr Hematol Oncol. 20 (4): 327–9. PMID 9703006.